Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 3, 2012, Pages 278-284

  Malentacchi, Francesca ^a   Vinci, Serena ^a   Melina, Alessandro Della ^a   Kuncova, Jitka ^b   Villari, Donata ^a   Giannarini, Gianluca ^b   Nesi, Gabriella ^a   Selli, Cesare ^b   Orlando, Claudio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Alternative splicing; Bladder cancer; CAIX; Hypoxia; Urine sediment

Indexed keywords

CARBONATE DEHYDRATASE IX; ISOENZYME; MESSENGER RNA;

ARTICLE; BENIGN TUMOR; BLADDER CANCER; CANCER PATIENT; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINE SEDIMENT;

ALTERNATIVE SPLICING; ANOXIA; CARBONIC ANHYDRASES; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; CELL PROLIFERATION; EXONS; FEMALE; HUMANS; MALE; PROTEIN ISOFORMS; RNA, MESSENGER; ROC CURVE; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 84860292603     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.05.009     Document Type: Article

References (31)

1. Babjuk M., Oosterlinck W., Sylvester R., et al. European Association of Urology (EAU). EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008, 54:303-314.
2. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., et al. Primary superficial bladder cancer risk groups according to progression, mortality, and recurrence. J Urol 2000, 164:680-684.
3. Rouprêt M., Hupertan V., Yates D.R., et al. A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis. BJU Int 2008, 101:1448-1453.
4. Graeber T.G., Osmanian C., Jacks T., et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996, 379:88-91.
5. Ruan K., Song G., Ouyang G. Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 2009, 107:1053-1062.
6. Giatromanolaki A., Koukourakis M.I., Sivridis E., et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 2001, 61:7992-7998.
7. Sly W.S., Hu P.Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995, 64:375-401.
8. Hilvo M., Tolvanen M., Clark A., et al. Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem J 2005, 392:83-92.
9. Beasley N.J., Wykoff C.C., Watson P.H., et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 2001, 61:5262-5267.
10. Thiry A., Dogné J.M., Masereel B., et al. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol Sci 2006, 27:566-573.
11. Klatte T., Seligson D.B., Rao J.Y., et al. Carbonic anhydrase IX in bladder cancer: A diagnostic, prognostic, and therapeutic molecular marker. Cancer 2009, 115:1448-1458.
12. Barathova M., Takacova M., Holotnakova T., et al. Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumor phenotype. Br J Cancer 2008, 98:129-136.
13. Malentacchi F., Simi L., Nannelli C., et al. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. Lung Cancer 2009, 64:271-276.
14. Sauter G., Algaba F., Amin M., et al. Tumours of the urinary system: Non-invasive urothelial neoplasias. WHO Classification of Tumours of the Urinary System and Male Genital Organs 2004, 90-150. IARCC Press, Lyon. J.N. Eble, G. Sauter, J. Epstein (Eds.).
15. Sobin L.H., Wittekind C. TNM classification of malignant tumors 2002, Wiley-Liss, New York. 6th ed.
16. Hockel M., Vaupel P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001, 93:266-276.
17. Lundgren K., Holm C., Landberg G. Hypoxia and breast cancer: Prognostic and therapeutic implications. Cell Mol Life Sci 2007, 64:3233-3247.
18. Le Q.T., Courter D. Clinical biomarkers for hypoxia targeting. Cancer Metastasis Rev 2008, 27:351-362.
19. Koukourakis M.I., Bentzen S.M., Giatromanolaki A., et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2&;α and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 2006, 24:727-735.
20. Hoskin P.J., Sibtain A., Daley F.M., et al. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: Relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer 2003, 89:1290-1297.
21. Turner K.J., Crew J.P., Wykoff C.C., et al. The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs. invasive bladder cancer. Br J Cancer 2002, 86:1276-1282.
22. Hussain S.A., Palmer D.H., Ganesan R., et al. Carbonic anhydrase IX, a marker of hypoxia: Correlation with clinical outcome in transitional cell carcinoma of the bladder. Oncol Rep 2004, 11:1005-1010.
23. Ord J.J., Streeter E.H., Roberts I.S., et al. Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. Br J Cancer 2005, 93:346-354.
24. Ord J.J., Agrawal S., Thamboo T.P., et al. An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancer. J Urol 2007, 178:677-682.
25. Sherwood B.T., Colquhoun A.J., Richardson D., et al. Carbonic anhydrase IX expression and outcome after radiotherapy for muscle-invasive bladder cancer. Clin Oncol (R Coll Radiol) 2007, 19:777-783.
26. Kovtun Y.V., Goldmacher V.S. Cell killing by antibody-drug conjugates. Cancer Lett 2007, 255:232-240.
27. Zavada J., Zavadova Z., Zatovicova M., et al. Soluble form of carbonic anhydrase IX (CAIX) in the serum and urine of renal carcinoma patients. Br J Cancer 2003, 89:1067-1071.
28. Hyrsl L., Zavada J., Zavadova Z., et al. Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract. Neoplasma 2009, 56:298-302.
29. Raitanen M.P., Kaasinen E., Lukkarinen O., et al. Analysis of false-positive BTA STAT test results in patients followed up for bladder cancer. Urology 2001, 57:680-684.
30. Wald M., Halachmi S., Amiel G., et al. Bladder Tumor Antigen Stat test in non-urothelial malignant urologic conditions. Isr Med Ass J 2002, 4:174-175.
31. Ponsky L.E., Sharma S., Pandrangi L., et al. Screening and monitoring for bladder cancer: Refining the use of NMP22. J Urol 2001, 166:75-78.